In the current study, we analyzed the soluble forms of CTLA‐4 and PD‐1 and its ligands in patients with PMR and GCA and assessed whether different clinical, laboratory, and imaging characteristics could be attributed to the different expression and functions of immune checkpoint markers. Here, CTLA4 is linked to temporal arteritis.